A Safety and Tolerability Study of 42037788 (Referred to as CNTO 0007) Compared With Placebo in Patients Who Have Experienced Ischemic Cerebral Infarction (Also Known as Stroke)

NCT01273467 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

13

Enrollment

INDUSTRY

Sponsor class

Conditions

Stroke
Ischemia
Infarction

Interventions

DRUG: CNTO 0007 or placebo (Stage A)
DRUG: CNTO 0007 or placebo (Stage B)

Sponsor

Janssen Research & Development, LLC